<html><head><title>Oliv H strong</title>
<meta http-equiv="Content-Type" content="text/html">
<meta http-equiv="Author" name="Oliv H" content="strong">
<meta http-equiv="Author" name="strong" content="levels">
<meta name="Language" content="de-en">
<meta name="Keywords" lang="de" content="strong, Oliv H, levels">
<meta name="Keywords" lang="en" content="Oliv H, strong, , levels">
<meta name="Description" lang="al "content=" The small number of cardiovascular events in the DCCT precluded detection of any cardioprotective effects, despite a tantalizing trend. Although surrogate primary end points were studied, the effect size and consistency of the effect across different end points in this and other studies led to widespread acceptance of tight glucose control for prevention of microvascular complications in type 1 diabetes. Until now, the DCCT results were generalized to patients with type 2 diabetes, without strong direct evidence in this group. The United Kingdom Prospective Diabetes Study (UKPDS) now provides direct evidence of a policy of intensive blood glucose control for patients with type 2 diabetes. In contrast to the DCCT, the UKPDS used "hard" clinical primary end points and a variety of interventions.">
<meta name="Revisit-after" content="1 month">
<meta name="Date_modified" content="2001-06-14">
<meta name="ROBOTS" content="index,follow">
</head>
<style type="text/css"> 
	A.nav:link {TEXT-DECORATION: none}
	A.nav:visited {TEXT-DECORATION: none} 
	A.nav:visited {TEXT-DECORATION: none}
	A.nav:active {TEXT-DECORATION: none}
	A.nav:hover {TEXT-DECORATION: none}
	</style><body bgcolor="#FFFFF">
	<font face="arial" size="3" color="#000000">
	<table border="0" cellpadding="0" cellspacing="0" width="100%">
	<tr><td><a href="levels.html" class="nav">levels</a></td></tr>
	<tr><td><a href="index.html" class="nav">home page</a></td></tr></table>
	<br><div align="center"><font size="6">- strong -<br><br></font></div>
<table width="100%" border="0" cellspacing="1" cellpadding="5"
<td valign="center">
</td>
<tr>
</table>
<table width="100%" border="0" cellspacing="2" cellpadding="5"
<td valign="center">
 The small number of cardiovascular events in the DCCT precluded detection of any cardioprotective effects, despite a tantalizing trend. Although surrogate primary end points were studied, the effect size and consistency of the effect across different end points in this and other studies led to widespread acceptance of tight glucose control for prevention of microvascular complications in type 1 diabetes. Until now, the DCCT results were generalized to patients with type 2 diabetes, without strong direct evidence in this group. The United Kingdom Prospective Diabetes Study (UKPDS) now provides direct evidence of a policy of intensive blood glucose control for patients with type 2 diabetes. In contrast to the DCCT, the UKPDS used "hard" clinical primary end points and a variety of interventions.</td>
<td valign="center"><img height="165" width="750" src="http://www.ucar.edu//ucar_graphics/title.jpg"></td>
<tr>
</table>
<table width="100%" border="0" cellspacing="2" cellpadding="5">
<td valign="center"><img HEIGHT=153 WIDTH=138 src="http://www.niddk.nih.gov/health/diabetes/pubs/dcct1/../../images/dmside.gif"></td>
<td valign="center">
</td>
<tr>
</table>
<table width="100%" border="0" cellspacing="2" cellpadding="2"
<td valign="center">
 The small number of cardiovascular events in the DCCT precluded detection of any cardioprotective effects, despite a tantalizing trend. Although surrogate primary end points were studied, the effect size and consistency of the effect across different end points in this and other studies led to widespread acceptance of tight glucose control for prevention of microvascular complications in type 1 diabetes. Until now, the DCCT results were generalized to patients with type 2 diabetes, without strong direct evidence in this group. The United Kingdom Prospective Diabetes Study (UKPDS) now provides direct evidence of a policy of intensive blood glucose control for patients with type 2 diabetes. In contrast to the DCCT, the UKPDS used "hard" clinical primary end points and a variety of interventions.</td>
<tr>
</table>
<br>A site I really like: <a href="http://www.isr.umd.edu/ISR/industry.html">http://www.isr.umd.edu/ISR/industry.html</a><br><br>
</font><font size=-6> <a class="nav" href="">.</a><br><br>
</font></body></html>
